e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros
Source:
ERJ Open Res, 6 (4) 00152-2020; 10.1183/23120541.00152-2020
Journal Issue:
October
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros. Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study. ERJ Open Res, 6 (4) 00152-2020; 10.1183/23120541.00152-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study.
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021
A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016
Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020
Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study.
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Single-center prospective study on clinical evolution of non-specific pleuritis
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018
Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
COVID-19 pneumonia and clinical follow-up: results of a prospective cohort
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017
Efficacy and safety of sequential three-step empirical therapy for chronic cough: a multi-center clinical study
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
A retrospective observational study to characterize severe eosinophilic asthma in Taiwan
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Chronic cough in routine clinical practice: a UK retrospective cohort study
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept